Showing 1 - 10 of 153
Count Initiative (MEBCI) implemented by local and international partners in 2013 in Ghana aimed at attaining neonatal … mortality of 21 per 1000 livebirths by 2018 in four administrative regions in Ghana. MEBCI interventions benefited 4027 health … may be potentially unsustainable for Ghana's health system. Emerging digital training platforms could be leveraged to …
Persistent link: https://www.econbiz.de/10012483141
Introduction: Ghana experienced its worst cholera outbreak in three decades in 2014. Evidence of cholera economic costs … cholera outbreak in a Coastal Region of Ghana. Methods: Two districts; High and Low Incidence Areas (HIA and LIA) were …
Persistent link: https://www.econbiz.de/10011764170
Introduction: Ghana introduced capitation payment under National Health Insurance Scheme (NHIS), beginning with pilot … regions of Ghana, one being an intervention region and two being control regions, over a 5-year period, 2010–2014. We … positive results. Health policy makers in Ghana may, therefore, want to consider capitation a key provider payment method for …
Persistent link: https://www.econbiz.de/10011896542
Objectives To optimise planning of public health services, the impact of high-cost users needs to be considered. However, most of the existing statistical models for costs do not include many clinical and social variables from administrative data that are associated with elevated health care...
Persistent link: https://www.econbiz.de/10014500224
Background: Côte d’Ivoire’s current health care financing system results from successive reforms undertaken with government funding and international support. The country is moving towards a national compulsory health insurance scheme. This context offered an opportunity to study additional...
Persistent link: https://www.econbiz.de/10011982688
This study provides an overview of policy measures targeting pharmaceutical expenditure in Europe and analyses their impact on originator pharmaceutical prices. Panel data methods are used to examine the market of ACE Inhibitors in six European countries (Denmark, France, Germany, Netherlands,...
Persistent link: https://www.econbiz.de/10009503923
We study the effects of "balance billing", i.e., allowing physicians to charge a fee from patients in addition to the fee paid by Medicare. First, we show that on pure efficiency grounds the optimal Medicare fee under balance billing is zero. An active Medicare policy thus can only be justified...
Persistent link: https://www.econbiz.de/10009503927
Background: This study identified per patient resource use and staff costs at a cystic fibrosis (CF) outpatient unit from the health care provider's perspective. Methods: Personnel cost data were prospectively collected for all CF outpatients (n = 126) under routine conditions at the Charité...
Persistent link: https://www.econbiz.de/10009503999
Background: The amount of out-of-pocket (OOP) payments within the German health care system has risen steadily within the last years. OOP payments aim to strengthen patients' cost awareness and try to restrict the demand on medical necessary treatments. However, besides the intended decline of...
Persistent link: https://www.econbiz.de/10010526631
Objectives: To evaluate the long-term cost-effectiveness of ticagrelor and ASA versus generic and branded clopidogrel and ASA in patients with ACS based on a Thai cost database. Methods: A one-year decision tree and a long-term Markov model were constructed to estimate lifetime costs and...
Persistent link: https://www.econbiz.de/10010526870